Importance: The placebo effect in depression clinical trials is a substantial factor associated with failure to establish efficacy of novel and repurposed treatments. However, the magnitude of the placebo effect and whether it differs across treatment modalities in treatment-resistant depression (TRD) is unclear.
Objective: To examine the magnitude of the placebo effect in patients with TRD across different treatment modalities and its possible moderators.